
BBIO Technical Analysis Summary (NASDAQ)
Analyze BBIO on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerBBIO Technical Analysis Summary (NASDAQ)
BridgeBio Pharma, Inc. (NASDAQ: BBIO) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest BridgeBio Pharma, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that BridgeBio Pharma, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 29.51
Stochastic %K: 3.85
Williams %R: -96.20
Rate of Change (ROC): -10.72
Takeaway:BridgeBio Pharma, Inc. shows oversold momentum, with rebound potential building.
MACD: -2.12
ADX: 18.93
ATR (14): 2.49
CCI (14): -117.20
Takeaway:BridgeBio Pharma, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:BridgeBio Pharma, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:BridgeBio Pharma, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:BBIO shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for BridgeBio Pharma, Inc. are mixed, suggesting a Hold or wait-and-see approach.